专题：Pharmaceutical Quality and Counterfeiting

This cluster of papers focuses on the global impact of counterfeit drugs, particularly in the context of antimalarial and other essential medicines. It addresses the public health risks, pharmaceutical counterfeiting, medicine adulteration, and the development of detection technologies to combat the proliferation of counterfeit drugs. The cluster also discusses the challenges associated with online pharmacies and emphasizes the importance of ensuring drug quality for patient safety.
最新文献
Detection of chemical drug adulterants in herbal supplements: A GC-MS identification of paracetamol, prednisone, and prednisolone

article Full Text OpenAlex

Role of the Community Pharmacists in Generic Prescribing in India: A Review

review Full Text OpenAlex

Chemical Standardization of Natural Remedies in the Raw and Pharmaceutical Forms

book-chapter Full Text OpenAlex

ASSESSING ALLERGENIC INGREDIENTS IN COSMECEUTICALS: A COMPREHENSIVE REVIEW OF ALLERGENS IN THE US MARKET

review Full Text OpenAlex

Raman Spectroscopy for Qualitative Analysis of Metformin HCl Tablets Through Blister Package

book-chapter Full Text OpenAlex

Stakeholder views on the implementation of the UK’s Antimicrobial Resistance (AMR) National Action Plan (2019–2024) in relation to AMR in the environment

article Full Text OpenAlex

Verifying Medical Legitimacy in India’s E-Pharmacy Sector: A Study on the Authenticity of Medical Professionals in E-Pharma Transactions Lacking Physical Prescriptions in India

article Full Text OpenAlex

Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk

article Full Text OpenAlex

A nationwide survey of antimicrobial stewardship infrastructure and CDC core elements in the Dominican Republic

article Full Text OpenAlex

Supply-chain vulnerabilities in critical medicines: A persistent risk to pharmaceutical security

article Full Text OpenAlex

近5年高被引文献
A Detailed Case Study on Deviation, Out-of-Specification(OOS) and CAPA Generation in Pharmaceutical Industry

article Full Text OpenAlex 961 FWCI928.012

Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants

review Full Text OpenAlex 561 FWCI6.467

Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review

review Full Text OpenAlex 452 FWCI20.59

Patients’ beliefs toward generic medication in Yemen

article Full Text OpenAlex 312 FWCI54.373

A Blockchain-Based Approach for Drug Traceability in Healthcare Supply Chain

article Full Text OpenAlex 289 FWCI69.48

Drug Shortage: Causes, Impact, and Mitigation Strategies

review Full Text OpenAlex 214 FWCI10.96

Blockchain Medledger: Hyperledger fabric enabled drug traceability system for counterfeit drugs in pharmaceutical industry

article Full Text OpenAlex 195 FWCI46.41

Report of the International Narcotics Control Board for 2023

book Full Text OpenAlex 176 FWCI14.101

Blockchain-enabled pharmaceutical cold chain: Applications, key challenges, and future trends

article Full Text OpenAlex 176 FWCI42.611

Blockchain-based smart tracking and tracing platform for drug supply chain

article Full Text OpenAlex 162 FWCI36.64